ScholarIQanswers from OpenAlex & ORCID
Simon Travis
ResearcherPublications, citations & collaboration network
Simon Travis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Simon Travis have?
ScholarIQindexed works
Simon Travis has 867 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Simon Travis have?
ScholarIQcitation count
Simon Travis has 43,254 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Simon Travis?
ScholarIQh-index
Simon Travis has an h-index of 97 in OpenAlex.
What is the i10-index of Simon Travis?
ScholarIQi10-index
Simon Travis has an i10-index of 318 in OpenAlex.
What is the ORCID of Simon Travis?
ScholarIQorcid
The ORCID for Simon Travis is on the source record.
What is the OpenAlex record for Simon Travis?
ScholarIQopenalex
The OpenAlex for Simon Travis is on the source record.
What are the most-cited papers on Simon Travis?
ScholarIQmost cited works
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignaß, James O. Lindsay, Andreas Sturm, Alastair Windsor, Jean–Frédéric Colombel, Mathieu Allez, Gert D'Haens, André D’Hoore, Gerassimos J. Mantzaris, Gottfried Novacek, Tom Öresland, Walter Reinisch, Miquel Sans, Eduard F. Stange, Séverine Vermeire, Simon Travis, Gert Van Assche
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter Higgins, Jan Wehkamp, Brian G. Feagan, Michael Yao, Marek Karczewski, Jacek Karczewski, Nicole Pezous, Stephan Bek, Gerard Bruin, Bjoern Mellgard, C Berger, Marco Londei, Arthur P. Bertolino, Gervais Tougas, Simon Travis, for the Secukinumab in Crohn's Disease Study Group
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
Axel Dignaß, Gert Van Assche, James O. Lindsay, Marc Lémann, Johan D. Söderholm, Jean‐Frédéric Colombel, Silvio Danese, A. D’Hoore, M.À. Gassull, Fernando Gomollón, Daan W. Hommes, Pierre Michetti, Colm O’Morain, Tom Öresland, Alastair Windsor, Eduard F. Stange, Simon Travis
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche, Axel Dignaß, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D’Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelić, Johan D. Söderholm, Johanna C. Escher, Sibylle Koletzko, Kaija‐Leena Kolho, Milan Lukáš, Christian Mottet, Herbert Tilg, Séverine Vermeire, F. Carbonnel, A.T. Cole, Gottfried Novacek, Max Reinshagen, Epameinondas V. Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kießlich, Eduard F. Stange, Simon Travis, James O. Lindsay